Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Total Revenue of $185.74 million for the year ending 2025.
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -28.3% in Total Revenue from 2024 to 2025.
- This data is from MARAVAI LIFESCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $50.98 million | Q2 2020: $46.91 million | Q3 2020: $87.86 million | Q1 2021: $148.21 million | Q2 2021: $217.78 million | Q3 2021: $204.81 million | Q1 2022: $244.29 million | Q2 2022: $242.73 million | Q3 2022: $191.26 million | Q1 2023: $79.03 million | Q2 2023: $68.91 million | Q3 2023: $66.87 million | Q1 2024: $64.18 million | Q2 2024: $69.42 million | Q3 2024: $69.03 million | Q1 2025: $46.85 million | Q2 2025: $47.40 million | Q3 2025: $41.63 million.
- Over the full 7 years of available data (2019 to 2025), MARAVAI LIFESCIENCES HOLDINGS, INC.'s Total Revenue has grown by 29.8%.
- Historical annual values: Fiscal year 2025: $185.74 million | Fiscal year 2024: $259.19 million | Fiscal year 2023: $288.95 million | Fiscal year 2022: $883.00 million | Fiscal year 2021: $799.24 million | Fiscal year 2020: $284.10 million | Fiscal year 2019: $143.14 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: